Resonant Capital Advisors’s Gilead Sciences GILD Stock Holding History

Resonant Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.8M	Buy	30,095 +49	+0.2%	+$6.46K	0.18%	91
2026 Q1	$4.19M	Buy	30,046 +2,146	+8%	+$301K	0.22%	75
2025 Q4	$3.42M	Buy	27,900 +3,500	+14%	+$425K	0.19%	90
2025 Q3	$2.71M	Buy	24,400 +3,322	+16%	+$378K	0.16%	103
2025 Q2	$2.34M	Buy	21,078 +2,169	+11%	+$231K	0.15%	108
2025 Q1	$2.12M	Buy	18,909 +1,427	+8%	+$147K	0.15%	105
2024 Q4	$1.61M	Buy	17,482 +2,441	+16%	+$220K	0.12%	119
2024 Q3	$1.26M	Buy	+15,041	New	+$1.15M	0.09%	136
2024 Q2	–	Sell	-3,050	Closed	-$223K	–	345
2024 Q1	$223K	Buy	3,050 +342	+13%	+$26.3K	0.02%	315
2023 Q4	$219K	Buy	+2,708	New	+$211K	0.02%	270
2023 Q3	–	Sell	-2,646	Closed	-$204K	–	275
2023 Q2	$204K	Buy	+2,646	New	+$211K	0.02%	260
2023 Q1	–	Sell	-2,358	Closed	-$202K	–	255
2022 Q4	$202K	Sell	2,358 -1,425	-38%	-$113K	0.03%	253
2022 Q3	$233K	Buy	3,783 +421	+13%	+$26.5K	0.04%	206
2022 Q2	$208K	Buy	+3,362	New	+$208K	0.03%	224

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Resonant Capital Advisors's GILD Position: Q2 2026 in Review

Resonant Capital Advisors increased its Gilead Sciences (GILD) stake by 0.16% in Q2 2026, buying an estimated $6.46K and bringing the position to 30,095 shares worth $3.8M. The position accounts for 0.18% of the portfolio, ranked #91.

Resonant Capital Advisors first reported a position in GILD in Q2 2022 and has held it in 14 quarters since. The position peaked at $4.19M in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Resonant Capital Advisors held 30,095 shares of Gilead Sciences worth $3.8M as of Q2 2026.
Resonant Capital Advisors bought 49 Gilead Sciences shares in Q2 2026, an estimated $6.46K.
Gilead Sciences made up 0.18% of Resonant Capital Advisors's portfolio in Q2 2026, its #91 holding.
Resonant Capital Advisors first reported a position in Gilead Sciences in Q2 2022 and has held it in 14 quarters since.
Resonant Capital Advisors's Gilead Sciences position peaked at $4.19M in Q1 2026.
1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.